Lack of evidence for CDK12 as an ovarian cancer predisposing gene
- 1 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Familial Cancer
- Vol. 19 (3), 203-209
- https://doi.org/10.1007/s10689-020-00169-2
Abstract
CDK12 variants were investigated as a genetic susceptibility to ovarian cancer in a series of 416 unrelated and consecutive patients with ovarian carcinoma and who carry neither germline BRCA1 nor BRCA2 pathogenic variant. The presence of CDK12 variants was searched in germline DNA by massive parallel sequencing on pooled DNAs. The lack of detection of deleterious variants and the observed proportion of missense variants in the series of ovarian carcinoma patients as compared with all human populations strongly suggests that CDK12 is not an ovarian cancer predisposing gene.Funding Information
- Université de Rouen
- Ligue Contre le Cancer
- Agence Nationale de la Recherche (ANR10-INBS-09-08, ANR-10-EQPX-03)
This publication has 28 references indexed in Scilit:
- Germline RAD51C mutations confer susceptibility to ovarian cancerNature Genetics, 2012
- Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing dataBioinformatics, 2011
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genesGenes & Development, 2011
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing SignalsJournal of Computational Biology, 2004
- Hereditary Ovarian CancerInternational Journal of Gynecological Pathology, 1992